On May 18, 2022, MiMedx Group, Inc. filed an investor presentation with the U.S. Securities and Exchange Commission in connection with its 2022 annual meeting of shareholders, which is scheduled to be held on June 7, 2022. The Company stated that the presentation, and other important shareholder materials, are available at www.VoteMIMEDX.com. The Company added that it urges shareholders to vote for its Director nominees James L. Bierman and Phyllis Gardner on the Company's proxy card.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.43 USD | -1.23% | +1.58% | -26.68% |
Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.68% | 961M | |
-18.52% | 131M | |
+7.32% | 63.05M | |
-15.34% | 61.84M | |
+1.20% | 50.36M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- MiMedx Group Files an Investor Presentation to Shareholders